drugset / Trial / NCT00003686

Pilocarpine in Treating Patients With Dry Mouth Caused by Opioids

NCT00003686

Phase 3 Terminated 4 enrolled NCIC Clinical Trials Group
RandomizedParallel-groupTriple-blindSupportive care

Summary

RATIONALE: Pilocarpine may help to relieve dry mouth in patients receiving opioids for cancer therapy. It is not yet known whether pilocarpine is more effective than no further treatment for this condition. PURPOSE: Randomized phase III trial to determine the effectiveness of pilocarpine in treating patients who have dry mouth caused by opioids.

Timeline

Start
1998-05-22
Primary completion
2007-11-01
Completion
2008-12-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pilocarpine Unknown 5 mg Oral

Indications